dehydroepiandrosterone has been researched along with medroxyprogesterone acetate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sasagawa, I; Satomi, S | 1 |
| Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH | 1 |
| Katayama, T; Sasagawa, I; Satomi, S | 1 |
| Schmidt, NA; Thijssen, JH; Trienekens, PH | 1 |
| Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE | 1 |
| Damber, JE; Ljungberg, B; Tomić, R | 1 |
| Bygdeman, M; de la Torre, B; Gottlieb, C; Hedman, M; Svanborg, K | 1 |
| Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM | 1 |
| Doorenbos, H; Pratt, JJ; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH | 1 |
| Fournier, M; Labrie, C; Labrie, F; Li, S; Martel, C; Pelletier, G; Picard, S; Sourla, A; Stojanovic, M | 1 |
| Dvorakova, M; Hampl, R; Hill, M; Lebl, J; Lisa, L; Snajderova, M; Starka, L; Sulcova, J | 1 |
| Bernardi, F; Casarosa, E; Gabbanini, M; Genazzani, AD; Genazzani, AR; Luisi, M; Palumbo, M; Picciarelli, G; Pieri, M; Pluchino, N | 1 |
1 trial(s) available for dehydroepiandrosterone and medroxyprogesterone acetate
| Article | Year |
|---|---|
Adrenal steroids as parameters of the bioavailability of MA and MPA.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate | 1990 |
14 other study(ies) available for dehydroepiandrosterone and medroxyprogesterone acetate
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin | 1990 |
[Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Topics: Adrenocorticotropic Hormone; Back Pain; Bone and Bones; Bone Neoplasms; Chlormadinone Acetate; Dehydroepiandrosterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging | 1989 |
The effect of age, weight-related parameters and hormonal contraceptives on andrological assays.
Topics: Age Factors; Body Weight; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Reference Values; Sex Hormone-Binding Globulin; Testosterone | 1986 |
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone | 1987 |
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Dehydroepiandrosterone; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prolactin; Prostatic Neoplasms; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Delayed-Action Preparations; Dihydrotestosterone; Estradiol; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnenolone; Semen; Testosterone | 1988 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
Studies on ovarian and adrenal studies at different phases of the menstrual cycle. IV. The effect of dexamethasone suppression and subsequent ACTH stimulation at different phases of the menstrual cycle and following the administration of 150 mg of depot-m
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone; Delayed-Action Preparations; Dexamethasone; Estradiol; Female; Humans; Hydrocortisone; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Ovary; Pregnenolone; Progesterone; Steroids | 1981 |
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients.
Topics: Adrenocorticotropic Hormone; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones | 1984 |
Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.
Topics: Androgen Antagonists; Animals; Benzopyrans; Bone Density; Cholesterol; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Femur; Flutamide; Medroxyprogesterone Acetate; Ovariectomy; Progesterone Congeners; Propionates; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1998 |
Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Adult; Androstenedione; Biomarkers; Child; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Female; Human Growth Hormone; Humans; Immunoradiometric Assay; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Progesterone; Sex Hormone-Binding Globulin; Testosterone; Turner Syndrome | 2001 |
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Topics: Administration, Cutaneous; Adrenal Glands; Aging; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovariectomy; Postmenopause; Pregnanolone; Progesterone; Progestins | 2005 |